|
US2019112336A1
|
|
Peptide for skin regeneration or wound treatment and use thereof
|
|
KR20190031182A
|
|
Use of a peptide as a therapeutic agent for autoimmune disease or bone disease
|
|
KR20190031185A
|
|
Use of a peptide as a therapeutic agent for autoimmune disease
|
|
KR20190031184A
|
|
Use of a peptide as a therapeutic agent for autoimmune disease or bone disease
|
|
WO2019054809A2
|
|
Use of peptides as therapeutic agent for autoimmune diseases and bone diseases
|
|
KR20190031183A
|
|
Use of a peptide as a therapeutic agent for autoimmune disease
|
|
WO2019054808A2
|
|
Use of peptides as therapeutic agent for autoimmune diseases and bone diseases
|
|
KR20190031070A
|
|
Use of a peptide as a therapeutic agent
|
|
KR20190031074A
|
|
Use of a peptide as a therapeutic agent
|
|
WO2017164609A2
|
|
Peptide for skin regeneration or wound treatment and use thereof
|
|
EP3428178A1
|
|
Peptide for preventing or treating inflammatory diseases and use thereof
|
|
WO2017155234A1
|
|
Peptide for preventing or treating inflammatory diseases and use thereof
|
|
KR20170106167A
|
|
Peptides for treating inflammatory diseases and use thereof
|
|
KR20170106168A
|
|
Peptides for treating inflammatory diseases and use thereof
|
